By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: More Clinical Research Trials Moving to China
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Business > More Clinical Research Trials Moving to China
Business

More Clinical Research Trials Moving to China

BarbaraDuck
BarbaraDuck
Share
5 Min Read
SHARE

So many still think that doctors are highly paid positions and that’s not necessary so.  It does cost money and takes time to do research as quoted in this article from Reuters, so they quit.  In the meantime China’s world of clinical trials are growing and some pharma companies said that they can’t afford to conduct trials in the US.

So many still think that doctors are highly paid positions and that’s not necessary so.  It does cost money and takes time to do research as quoted in this article from Reuters, so they quit.  In the meantime China’s world of clinical trials are growing and some pharma companies said that they can’t afford to conduct trials in the US.

Dr. Wes was also talking this week about re-certification to remain board certified in cardiology,for his 2 certifications and then there’s no compensation for any time off work to attend.  To conduct clinical trials of course there’s some certifications involved here depending on the trial.  In other countries income for doctors who do clinical trials do have an increase in income for their time and efforts.  Again with our current healthcare model, if you can call it that in the US, is skewed to where the processes we have and some of the software reporting gets too complicated and too involved to encourage more to participate. 

Also worth a mention is “time” and some are finding it tough enough just to take care of patients without the adding on trials to their already over burdened schedule.  You could almost forget any physician working in a busy hospital environment whether it be a full or part time hospitalist as they have to focus on coding so they would have no time here but on the other hand probably get a better view of patients who would be able to participate as they see everything when admitting.  BD

More Read

Top Quotes of the Week
Population Health Management [INFOGRAPHIC]
Connected Health Predictive Analytics: A Long Road Ahead
Health Insurance Premium Increases in Massachusetts
How To Launch A Maternity Center In The USA

The Hospitalists Have Become The Gatekeepers for Effective Hospital Coding & Sometimes Bear the Burden Alone

Under the surface, however, a growing number of doctors are worried about the tectonic changes in drug research. They resent the export of clinical trial work, which they blame not only on industry’s endless pursuit of lower costs but also on the increasing red tape surrounding trial procedures at home.

“Many of my colleagues have just thrown in the towel and say ‘I’m not going to do clinical research anymore’,” says Dr. Michael Crawford, professor of medicine and chief of clinical cardiology at University of California-San Francisco, one of the top medical schools in the United States.

“It’s pervasive. They’ve just quit clinical trial work. It’s just too difficult and the expenses are so high you end up being in the red when you do a study.”

For now, the world’s emerging economies still play second fiddle to the United States when it comes to testing drugs. Clinicaltrials.org, a website run by the U.S. National Institutes of Health, currently lists more than 106,000 trials around the world, of which just over 50 percent are in the United States. But the balance is shifting, particularly when it comes to the big late-stage trials that really matter in deciding whether a drug is approved for sale. U.S. centers account for only 43 percent of the nearly 19,000 trials in final Phase III testing.

“Drug companies will surely vie for such a market,” says Zhang. “Now, more Chinese can afford to buy Western-made drugs. So instead of performing a trial in China only after completing trials in Europe or the U.S., why not conduct them all at the same time?”

SPECIAL REPORT-Big Pharma’s global guinea pigs | Reuters

 

TAGGED:clinical research trialshealth care business
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

contamination
Batch Failures And The Hidden Costs Of Contamination
Health Infographics
October 21, 2025
Medication Management For Seniors
Simplifying Medication Management For Seniors
Infographics Senior Care
October 21, 2025
Guide To Pursuing a Career in Nursing as a Foreigner in the USA
Collaboration Is the Prescription for Better Patient Care
Health
October 20, 2025
Epidemiological Health Benefits
Personal and Epidemiological Health Benefits of Blood Pressure Management
Health
October 13, 2025

You Might also Like

hand sanitizer
Business

10 Most Overhyped Health Products on the Market

May 7, 2012
Image
BusinesseHealthSocial Media

Beyond the Buzz: 7 Reasons Healthcare Professionals Should Blog

August 29, 2014

Health Care Buzz Today

May 5, 2011

Your Employees Are Your Best Brand Ambassadors

August 6, 2014
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?